Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 334

1.

Platinum(ii) complexes with rutaecarpine and tryptanthrin derivatives induce apoptosis by inhibiting telomerase activity and disrupting mitochondrial function.

Qin QP, Zou BQ, Hu FL, Huang GB, Wang SL, Gu YQ, Tan MX.

Medchemcomm. 2018 Aug 8;9(10):1639-1648. doi: 10.1039/c8md00247a. eCollection 2018 Oct 1.

PMID:
30429969
2.

Combined effects of Lenvatinib and iodine-131 on cell apoptosis in nasopharyngeal carcinoma through inducing endoplasmic reticulum stress.

Wang G, Zhuang J, Ni J, Ye Y, He S, Xia W.

Exp Ther Med. 2018 Oct;16(4):3325-3332. doi: 10.3892/etm.2018.6652. Epub 2018 Aug 23.

3.

Povidone-iodine results in rapid killing of thymic epithelial tumour cells through cellular fixation.

Lee HS, Jang HJ, Lo EM, Truong CY, Groth SS, Friedberg JS, Sugarbaker DJ, Burt BM.

Interact Cardiovasc Thorac Surg. 2018 Aug 27. doi: 10.1093/icvts/ivy248. [Epub ahead of print]

PMID:
30165653
4.

Diiodo-Bodipy-Encapsulated Nanoscale Metal-Organic Framework for pH-Driven Selective and Mitochondria Targeted Photodynamic Therapy.

Guan Q, Zhou LL, Li YA, Dong YB.

Inorg Chem. 2018 Aug 20;57(16):10137-10145. doi: 10.1021/acs.inorgchem.8b01316. Epub 2018 Aug 3.

PMID:
30074794
5.

β-Lapachone and its iodine derivatives cause cell cycle arrest at G2/M phase and reactive oxygen species-mediated apoptosis in human oral squamous cell carcinoma cells.

Dias RB, de Araújo TBS, de Freitas RD, Rodrigues ACBDC, Sousa LP, Sales CBS, Valverde LF, Soares MBP, Dos Reis MG, Coletta RD, Ramos EAG, Camara CA, Silva TMS, Filho JMB, Bezerra DP, Rocha CAG.

Free Radic Biol Med. 2018 Oct;126:87-100. doi: 10.1016/j.freeradbiomed.2018.07.022. Epub 2018 Jul 30.

PMID:
30071298
6.

Long Non-coding Antisense RNA TNRC6C-AS1 Is Activated in Papillary Thyroid Cancer and Promotes Cancer Progression by Suppressing TNRC6C Expression.

Muhanhali D, Zhai T, Jiang J, Ai Z, Zhu W, Ling Y.

Front Endocrinol (Lausanne). 2018 Jul 9;9:360. doi: 10.3389/fendo.2018.00360. eCollection 2018.

7.

LncRNA MEG3 enhances 131I sensitivity in thyroid carcinoma via sponging miR-182.

Liu Y, Yue P, Zhou T, Zhang F, Wang H, Chen X.

Biomed Pharmacother. 2018 Sep;105:1232-1239. doi: 10.1016/j.biopha.2018.06.087. Epub 2018 Jun 22.

PMID:
30021359
8.

Analysis of MLN4924 (pevonedistat) as a potential therapeutic agent in malignant melanoma.

Olaverria Salavaggione GN, Duggan MC, Carson WE.

Melanoma Res. 2018 Oct;28(5):390-397. doi: 10.1097/CMR.0000000000000474.

PMID:
30020196
9.
10.

Synthesis, characterization and biological activity of new cyclometallated platinum(iv) complexes containing a para-tolyl ligand.

Solé M, Balcells C, Crespo M, Quirante J, Badia J, Baldomà L, Font-Bardia M, Cascante M.

Dalton Trans. 2018 Jul 10;47(27):8956-8971. doi: 10.1039/c8dt01124a.

PMID:
29922789
11.

LncRNA BISPR promotes the progression of thyroid papillary carcinoma by regulating miR-21-5p.

Zhang H, Cai Y, Zheng L, Zhang Z, Lin X, Jiang N.

Int J Immunopathol Pharmacol. 2018 Jan-Dec;32:2058738418772652. doi: 10.1177/2058738418772652.

PMID:
29856242
12.

The Possible Mechanisms of HSV-TK/Hyperthermia Combined with 131I-antiAFPMcAb-GCV Nanospheres to Treat Hepatoma.

Lin M, Zhou C, Huang J, Tian W, Yu H, Jiang X, Ye J, Guo T, Shi Y, Xiao Y, Bian X, Feng X.

Anal Cell Pathol (Amst). 2018 May 3;2018:8941908. doi: 10.1155/2018/8941908. eCollection 2018.

13.

Amyloid-beta Interactions with ABC Transporters and Resistance Modifiers.

Molnar J, Ocsovszki I, Pusztai R.

Anticancer Res. 2018 Jun;38(6):3407-3410. doi: 10.21873/anticanres.12608.

PMID:
29848690
14.

Combined Strategy of Radioactive 125I Seeds and Salinomycin for Enhanced Glioma Chemo-radiotherapy: Evidences for ROS-Mediated Apoptosis and Signaling Crosstalk.

Liu C, Wang L, Qiu H, Dong Q, Feng Y, Li D, Li C, Fan C.

Neurochem Res. 2018 Jul;43(7):1317-1327. doi: 10.1007/s11064-018-2547-2. Epub 2018 May 26.

PMID:
29804240
15.

Synthesis and characterization of radioiodinated 3-phenethyl-2-indolinone derivatives for SPECT imaging of survivin in tumors.

Ishikawa N, Fuchigami T, Mizoguchi T, Yoshida S, Haratake M, Nakayama M.

Bioorg Med Chem. 2018 Jul 23;26(12):3111-3116. doi: 10.1016/j.bmc.2018.04.034. Epub 2018 Apr 17.

PMID:
29703424
16.

CLR 125 Auger Electrons for the Targeted Radiotherapy of Triple-Negative Breast Cancer.

Grudzinski J, Marsh I, Titz B, Jeffery J, Longino M, Kozak K, Lange K, Larrabee J, Weichmann A, Moser A, Bednarz B.

Cancer Biother Radiopharm. 2018 Apr;33(3):87-95. doi: 10.1089/cbr.2017.2376.

PMID:
29641256
17.

Expression of Bax and Bcl2 Genes in Peripheral Blood Lymphocytes of Patients with Differentiated Thyroid Cancer.

Hamivand Z, Haddadi G, Fardid R.

J Med Phys. 2018 Jan-Mar;43(1):41-45. doi: 10.4103/jmp.JMP_104_17.

18.

LARP7 in papillary thyroid carcinoma induces NIS expression through suppression of the SHH signaling pathway.

Sui X, Sui Y, Wang Y.

Mol Med Rep. 2018 Jun;17(6):7521-7528. doi: 10.3892/mmr.2018.8856. Epub 2018 Apr 5.

19.

Effects of nuclear factor‑κB on the uptake of 131iodine and apoptosis of thyroid carcinoma cells.

Chen F, Yin S, Zhu J, Jia L, Zhang H, Yang C, Liu C, Deng Z.

Mol Med Rep. 2018 Apr;17(4):4959-4964. doi: 10.3892/mmr.2018.8481. Epub 2018 Jan 25.

20.

The Combined Antitumor Effects of 125I Radioactive Particle Implantation and Cytokine-Induced Killer Cell Therapy on Xenograft Hepatocellular Carcinoma in a Mouse Model.

Zhang J, Wu N, Lian Z, Feng H, Jiang Q, Chen X, Gong J, Qiao Z.

Technol Cancer Res Treat. 2017 Dec;16(6):1083-1091. doi: 10.1177/1533034617732204. Epub 2017 Sep 25.

Supplemental Content

Loading ...
Support Center